(Q44357543)

2 December 2017

title

Suppression of granzyme B activity and caspase-3 activation in leukaemia cells constitutively expressing the protease inhibitor 9. (English)

1 reference

2 December 2017

1 reference

Kristina Fritsch

1

1 reference

2 December 2017

Jürgen Finke

series ordinal

2

1 reference

2 December 2017

Carsten Grüllich

series ordinal

3

1 reference

2 December 2017

publication date

28 July 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

92

1 reference

2 December 2017

issue

12

1 reference

2 December 2017

page(s)

1603-1609

1 reference

CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

The death receptor pathway is not involved in alloreactive T-cell induced mitochondrial membrane permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Role of Bid-induced mitochondrial outer membrane permeabilization in granzyme B-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Human and murine granzyme B exhibit divergent substrate preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Membrane receptors are not required to deliver granzyme B during killer cell attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Ex vivo detection of primary leukemia cells resistant to granule cytotoxin-induced cell death: a rapid isolation method to study granzyme-B-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Regulation of pro-apoptotic leucocyte granule serine proteinases by intracellular serpins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Granzyme B: pro-apoptotic, antiviral and antitumor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Apoptosis pathways in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Fas ligand is not constitutively expressed in low-grade B-cell lymphoma and B-lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

A central role for Bid in granzyme B-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1846-6

10.1007/S00277-013-1846-6

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference